Evolent Health, Inc. (EVH) company profile
Close on Nov 16, 2026Market cap $546.08MP/E –Yield –
About Evolent Health
Services-Management Services, SIC 8741
Evolent coordinates healthcare for individuals with complex conditions, including cardiovascular disease, cancer, and musculoskeletal disorders. The company operates through a single reportable segment and delivers two primary offerings: specialty care management services and administrative services. Its specialty care management platform assists in clinical decision-making, establishes provider networks, and develops evidence-based treatment pathways. Its administrative services provide health plan operations, risk management, pharmacy benefit management, and analytics supported by its proprietary technology platform. Evolent serves healthcare payers, health plans, and risk-bearing entities, while supporting affiliated medical providers who deliver patient care.
Geographically, the company markets and sells its solutions to healthcare payers and medical providers throughout the United States. Its operations reach regional and national health plans across Medicare, Medicaid, and commercial populations. The provided report does not disclose specific facility counts, physical office locations, or the location of its corporate headquarters.
Summary of the business section of Evolent Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Evolent Health, Inc.
- Founded
- 2011
- Headquarters
- Arlington, VA
- Address
- 1812 North Moore St, Suite 1705 22209
- Phone
- (571) 389-6000
- Website
- evolent.com
- Employees
- 4,200, Dec 31, 2025
- Industry
- Services-Management Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, McLean, VA
Stock & identifiers
- Ticker
- EVH
- Exchange
- NYSE
- IPO date
- Jun 5, 2015
- Shares outstanding
- 113M, Aug 1, 2026
- Public float
- $1.30B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1628908
- CUSIP
- 30050B101
- ISIN
- US30050B1017
- FIGI
- BBG005CHLM96
- Share class FIGI
- BBG005CHLMB3
- LEI
- 549300CZOCFHQ2BBTR11
- EIN
- 32-0454912
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Seth Blackley | Chief Executive Officer, Director | 1,272,767 |
| Daniel Joseph McCarthy | PRESIDENT | 655,133 |
| Jonathan Weinberg | General Counsel | 287,567 |
| Aammaad Shams | Chief Accounting Officer | 95,637 |
| Mario Ramos | Chief Financial Officer | 0 |
| John Paul Johnson | Chief Financial Officer | 309,245 |
| Emily Ann Rafferty | Chief Operating Officer | 132,561 |
| Brendan B. Springstubb | Director | 99,917 |
| Russell Monroe Glass | Director | 83,393 |
| Peter J. Grua | Director | 123,743 |
| Craig A. Barbarosh | Director | 95,031 |
| Shawn M. Guertin | Director | 63,075 |
| Richard M. Jelinek | Director | 107,533 |
| Kim Keck | Director | 102,597 |
| Jill D. Smith | Director | 64,233 |
| Toyin Ajayi | Director | 75,170 |
| Cheryl Scott | Director | 73,476 |
| Diane Holder | Director | 70,584 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $14.24M | $2.58M | $5.01M | $25 | $99 |
| FY2024 | $11.14M | -$9.30M | $4.07M | $70 | $81 |
| FY2023 | $8.93M | $20.11M | $3.19M | $206 | $82 |
| FY2023 Seth Blackley | $8.93M | $20.11M | $3.19M | $206 | $82 |
| FY2022 Frank Williams | $0 | $0 | $2.51M | $175 | $77 |
| FY2022 Seth Blackley | $7.73M | $11.80M | $2.51M | $175 | $77 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Seth Blackley Chief Executive Officer | $867.07K | $660.00K | $12.70M | $14.00K | $14.24M | +28% |
| John Johnson Former Chief Financial Officer; Chief Strategy Officer | $541.92K | $0 | $4.82M | $13.72K | $5.37M | +12% |
| Daniel McCarthy President | $650.30K | $495.00K | $8.47M | $11.92K | $9.62M | +29% |
| Emily Rafferty Former Chief Operating Officer; EVP, Customer Success | $454.34K | $277.17K | $1.66M | $13.78K | $2.40M | +20% |
| Jonathan Weinberg General Counsel | $460.36K | $262.97K | $1.90M | $14.00K | $2.64M | +34% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“As of February 16, 2026, we had approximately 4,200 global employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jan 23, 2023 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 4, 2020 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Dec 31, 2019 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Apr 10, 2019 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Oct 2, 2018 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Oct 3, 2016 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jun 5, 2015 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?